Speeple News Search

Sign Up! | Tags | Domains | Statistics | Options | Advanced Search

ADVENTRX’s ANX-514 (Docetaxel Emulsion) Demonstrated Positive Data from Preclinical Pharmacokinetic Testing [PharmaGazette]

knowmoremedia.com » 2007 » April » 27th » ADVENTRX’s ANX-514 (Docetaxel Emulsion) Demonstrated Positive Data from Preclinical Pharmacokinetic Testing [PharmaGazette]

Tagged: cancer, generic drugs, patents and clinical trials, cancer drugs

Preclinical pharmacokinetic testing of ANX-514 (docetaxel emulsion) in a well recognized animal model, yielded positive data as recently announced by ADVENTRX Pharmaceuticals, Inc. (Amex: ANX). Results of the study indicated the following: Bioequivalent pharmacokinetics between ANX-514 and the FDA-approved version of docetaxel: Taxotere® ANX-514 administered intravenously did not cause … Continue Reading »

Latest news from Know More Media - Health Care / Pharmaceutical / Fitness:

  1. Shire Warning Letter Is About Content, Not Context [HealthCareVox]
  2. Help Pew Tweak Its Next Internet Survey [HealthCareVox]
  3. If You’re Conducting Telephone Surveys You Must Include Cell-Only Population [HealthCareVox]
  4. More On Health 2.0: Are Consumers Central Or Secondary? [HealthCareVox]
  5. Health 2.0: Fad Or Fundamental? [HealthCareVox]

Latest news from knowmoremedia.com:

  1. A Memorandum in Colors
  2. A Memorandum in Colors [Webmetricsguru]
  3. Head for the Silicon Valley storm cellar. But get a value proposition first.
  4. Head for the Silicon Valley storm cellar. But get a value proposition first. [BrandingPost]
  5. Shire Warning Letter Is About Content, Not Context